FDA DRUG RESIDUE PREVENTION PROGRAM

FDA药物残留预防指南 RFA-FD-18-006 项目摘要 俄亥俄州农业部 这项来自俄亥俄州农业部（ODA）的拨款提案是为了回应 Food and Drug提供的资助机会公告RFA-FD-18-006 管理局（FDA）。 ODA的这一建议旨在发展俄亥俄州的药物残留预防 通过继续教育和推广活动，以积极主动的方式开展计划 从业者，生产者，公司和其他行业参与治疗和/或 或管理药用食品生产动物，与法律的额外标签相关的活动 药物在动物中的使用，以及其他与俄亥俄州药物残留预防有关的措施。 这将通过以下目标实现： 1.全行业的教育和推广，其中包括ODA的兽医 出席各种行业会议并在会上发言的管理人员 在整个国家;发展信息，以提供官方发展援助的 网站;以及制作小册子和概况介绍供分发。 2.对在工厂内存在违规药物残留的公司进行现场评估， 一年来评估将包括评估公司的药物使用和动物 药物实践，以确定无效或不当的做法，并 交流最佳残留预防实践，以防止未来 违法行为，确保食品安全。 3.对存在违规药物残留的公司进行现场最佳做法访问 近三年访问的重点将与评估一致， 但是，将更加注重向前推进的最佳做法。 药物残留预防计划的目标是看到更有效的管理 通过提高正确使用药物的意识和知识， 和额外的标签药物使用规定。我们预计， 非法药物残留在食用动物，最终目标是零组织 俄亥俄州的残留物违规

FDA DRUG RESIDUE PREVENTION PROGRAM RFA-FD-18-006 PROJECT SUMMARY OHIO DEPARTMENT OF AGRICULTURE This grant proposal from the Ohio Department of Agriculture (ODA) is in response to Funding Opportunity Announcement RFA-FD-18-006 offered by the Food and Drug Administration (FDA). The purpose of this proposal from ODA is to develop Ohio’s drug residue prevention program with a proactive approach, through continued education and outreach activities to practitioners, producers, firms, and other industry parties involved with treating and / or managing medicated food producing animals, activities related to legal extra label drug use in animals, and other measures related to drug residue prevention in Ohio. This will be achieved through the following objectives: 1. Industry-wide education and outreach, which will consist of ODA’s Veterinarian Administrators attending and presenting at various industry-wide meetings throughout the state; development of information to be available on ODA’s website; and the creation of brochures and factsheets for distribution. 2. On-site assessments with firms who have had violative drug residues within the past year. Assessments will include evaluation the firms’ drug usage and animal medication practices to identify ineffective or improper practices, and to communicate best residue prevention practices with intent to prevent future violations to ensure food safety. 3. On-site best practice visits with firms who have had violative drug residues within the past three years. The focus of the visits will be consistent with assessments, however, will have a heavier focus on best practices moving forward. The goal of the drug residue prevention program is to see more effective management of animal treatment, by increasing the awareness and knowledge of proper drug use and extra label drug use regulations. We would expect to see a continued reduction in illegal drug residues in food-producing animals, with an ultimate goal of zero tissue residue violations in Ohio.